In an effort to assist registered members of the press with planning coverage, the AAAAI issues press releases and provides abstract summaries in advance of the 2023 AAAAI Annual Meeting. However, all materials are embargoed according to the following:
• Abstracts accepted for presentation at the 2023 AAAAI Annual Meeting are published in an online supplement to The Journal of Allergy and Clinical Immunology (JACI), an official journal of the AAAAI. The abstract supplement will be posted online at jacionline.org and annualmeeting.aaaai.org on February 3, 2023. As of February 3, 2023, all abstract embargoes will be lifted and the findings and results of abstracts can be freely reported on and covered.
• AAAAI press releases will be posted within the Press area of annualmeeting.aaaai.org about a week in advance of the embargo lift, and these AAAAI press releases will also be embargoed until February 3, 2023 (unless otherwise noted).
Journalists deemed in violation of any AAAAI Communications policies will have their AAAAI Virtual Annual Meeting press privileges revoked.
AAAAI Virtual Annual Meeting program content may not be used to develop continuing medical education (CME) without advance permission from the AAAAI.
Exhibitors/Public Relations Professionals
Exhibitors and individuals representing academic institutions, industry, advertising, marketing or public relations firms should be aware that:
• Any press releases, media alerts, or related materials that discuss abstracts being presented at the 2023 Annual Meeting do not need to be reviewed in advance by the AAAAI, but please be aware that they must not indicate AAAAI endorsement or use the AAAAI logo.
• Any press releases, media alerts, or related materials that strictly promote the abstract title, authors, date/time of presentation (including the session details if the abstract is being presented in a session), and that it will be presented at the 2023 AAAAI Annual Meeting can be issued at any time. However, please note that only the aforementioned abstract details should be included and not the abstract results and findings. Any press releases, media alerts, or related materials describing the abstract results and findings must be embargoed until February 3, 2023, which is the date the abstracts will be published in an online supplement (please see the first bullet under the Embargoes section above).
• Under no conditions will lists of past or current registered press be made available.
Individuals, companies, organizations or institutions found in violation of these policies will have AAAAI Annual Meeting access revoked. Additional sanctions may apply.
Please direct questions about these policies to Megan Brown at (414) 272-6071 or email@example.com.